chuhaiyi@baidu.com

爱博泰克完成12亿元D轮融资；成都赜灵完成亿元A轮融资；康恩贝16.8亿元出让珍视明42%股权

2022-11-21
340
97

Author：Ebotec completed the round D financing of 1.2 billion yuan; Chengdu Geling completed a round A financing of 100 million yuan; Kang'enbei transferred 42% equity of Zhenshiming with 1.68 billion yuan
Source： iResearch

Introduction:Ebotec completed the round D financing of 1.2 billion yuan; Chengdu Geling completed a round A financing of 100 million yuan; Kang'enbei transferred 42% equity of Zhenshiming with 1.68 billion yuan

[Investment and Financing News DecembereightDay]Ebotec focuses on the construction of antibody platform and protein platform, and continuously introduces advanced antibody and protein technology to optimize the two platforms. The antibody platform includes rabbit polyclonal antibody platform, mouse monoclonal antibody platform and the newly introduced rabbit monoclonal antibody platform. Recently completed the D round of 1.2 billion yuanfinancing。

It is a familyinnovateDrug R&D and industrialization service providers,companyThe R&D pipeline covers the R&D of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by novel coronavirus pneumonia. Recently, the financing scale reached 106.5 million yuan in round A financing.

Zhenshiming Pharmaceutical Co., Ltd. is a manufacturer of Chinese and western medicine preparations. It has more than 40 varieties of eye drops, 6 products that have entered the national basic drug catalog, and 25 national medical insurance products. The total amount of equity financing completed a few days ago was 1.68 billion yuan.

Cross border information investment and financing news | Ebotec completed the round D financing of 1.2 billion yuan; Chengdu Geling completed a round A financing of 100 million yuan; Kang'enbei transferred 42% equity of Zhenshiming with 1.68 billion yuan

(This document isIrinetFor the reprint of exclusive original manuscript, please indicate the source)
The content of the article is created by the author, and the author is responsible for the authenticity, accuracy and legality of the content. Overseadia advocates respecting and protecting intellectual property rights. Without the permission of the author and/or this website, the content of this website may not be copied, reproduced, or used in other ways. If you find that there are copyright issues in the articles on this site, please contact chuhaiyi@baidu.com, and we will verify and deal with them in time. Source of the article: iResearch, this article is the author's independent point of view, and does not represent the position of overseadia.
Previous：In 2020, the market size of China's beauty collection stores industry will be 41.9 billion yuan, of which the new beauty collection stores will account for 7.6%. With the transition of the new beauty collection store industry from the embryonic stage to the stable development stage, its market share is expected to increase to 15.8% in 2023, and the market scale is expected to reach 13 billion yuan.
Next：Small and micro enterprises are an indispensable force in China's national economy and social development. They play a decisive role in increasing employment, increasing residents' income and maintaining social harmony and stability. From 2016 to 2020, the number of various market entities in China has increased from 87.054 million to 138.407 million, and the proportion of small and micro enterprises has also increased from 94.1% to 96.8%.
Terms of UsePrivacy Notice